Methylation of cyclin D2 is observed frequently in pancreatic cancer but is also an age-related phenomenon in gastrointestinal tissues

Clinical Cancer Research

Volumn 9, Issue 4, 2003, Pages 1446-1452

  Matsubayashi, Hiroyuki ^a,b   Sato, Norihiro ^a   Fukushima, Noriyoshi ^a   Yeo, Charles J ^a   Walter, Kimberly M ^a   Brune, Kieran ^a   Sahin, Fikret ^a   Hruban, Ralph H ^a   Goggins, Michael ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; CYCLIN D2; RNA; TUMOR MARKER;

ADULT; AGED; AGING; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; CPG ISLAND; DISEASE MARKER; DUODENUM; EPITHELIUM; FEMALE; GALLBLADDER; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; METHYLATION; PANCREAS ADENOCARCINOMA; PANCREAS CANCER; PANCREAS JUICE; PRIORITY JOURNAL; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR XENOGRAFT;

ADENOCARCINOMA; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; AZACITIDINE; CELL LINE, TUMOR; CYCLINS; DIGESTIVE SYSTEM; DNA METHYLATION; FEMALE; HUMANS; MALE; MIDDLE AGED; PANCREATIC JUICE; PANCREATIC NEOPLASMS; POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; TRANSFECTION;

EID: 0037389979     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Warshaw, A. L., and Fernandez-del Castillo, C. Pancreatic carcinoma. N. Engl. J. Med., 326: 455-465, 1992.
2. Furukawa, H., Okada, S., Saisho, H., Ariyama, J., Karasawa, E., Nakaizumi, A., Nakazawa, S., Murakami, K., and Kakizoe, T. Clinicopathologic features of small pancreatic adenocarcinoma. A collective study. Cancer (Phila.), 78: 986-990, 1996.
3. Sohn, T. A., Yeo, C. J., Cameron, J. L., Koniaris, L., Kaushal, S., Abrams, R. A., Sauter, P. K., Coleman, J., Hruban, R. H., and Lillemoe, K. D. Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators. J. Gastrointest. Surg., 4: 567-579, 2000.
4. Goggins, M., Canto, M., and Hruban, R. Can we screen high-risk individuals to detect early pancreatic carcinoma? J. Surg. Oncol., 74: 243-248, 2000.
5. Ueki, T., Toyota, M., Sohn, T., Yeo, C. J., Issa, J. P., Hruban, R. H., and Goggins, M. Hypermethylation of multiple genes in pancreatic adenocarcinoma. Cancer Res., 60: 1835-1839, 2000.
6. Fukushima, N., Sato, N., Ueki, T., Rosty, C., Walter, K. M., Wilentz, R. E., Yeo, C. J., Hruban, R. H., and Goggins, M. Aberrant methylation of preproenkephalin and p16 genes in pancreatic intraepithelial neoplasia and pancreatic ductal adenocarcinoma. Am. J. Pathol., 160: 1573-1581, 2002.
7. Sato, N., Ueki, T., Fukushima, N., Iacobuzio-Donahue, C. A., Yeo, C. J., Cameron, J. L., Hruban, R. H., and Goggins, M. Aberrant methylation of CpG islands in intraductal papillary mucinous neoplasms of the pancreas. Gastroenterology, 123: 365-372, 2002.
8. Evron, E., Umbricht, C. B., Korz, D., Raman, V., Loeb, D. M., Niranjan, B., Buluwela, L., Weitzman, S. A., Marks, J., and Sukumar, S. Loss of cyclin D2 expression in the majority of breast cancers is associated with promoter hypermethylation. Cancer Res., 61: 2782-2787, 2001.
9. Evron, E., Dooley, W. C., Umbricht, C. B., Rosenthal, D., Sacchi, N., Gabrielson, E., Soito, A. B., Hung, D. T., Ljung, B., Davidson, N. E., and Sukumar, S. Detection of breast cancer cells in ductal lavage fluid by methylation- specific PCR. Lancet. 357: 1335-1336, 2001.
10. Lehmann, U., Langer, F., Feist, H., Glockner, S., Hasemeier. B., and Kreipe, H. Quantitative assessment of promoter hypermethylation during breast cancer development. Am. J. Pathol., 160: 605-612, 2002.
11. Sherr, C. J. D-type cyclins. Trends Biochem Sci., 20: 187-190, 1995.
12. Meyyappan, M., Wong, H., Hull, C., and Riabowol, K. T. Increased expression of cyclin D2 during multiple states of growth arrest in primary and established cells. Mol. Cell. Biol., 18: 3163-3172, 1998.
13. Meyyappan, M., Atadja, P. W., and Riabowol, K. T. Regulation of gene expression and transcription factor binding activity during cellular aging. Biol. Signals, 5: 130-138, 1996.
14. Terris, B., Blaveri, E., Crnogorac-Jurcevic, T., Jones, M., Missiaglia, E., Ruszniewski, P., Sauvanet, A., and Lemoine, N. R. Characterization of gene expression profiles in intraductal papillary-mucinous tumors of the pancreas. Am. J. Pathol., 160: 1745-1754, 2002.
15. Moskaluk, C. A., and Kern, S. E. Microdissection and polymerase chain reaction amplification of genomic DNA from histological tissue sections. Am. J. Pathol., 150: 1547-1552, 1997.
16. Hrubam, R. H., Adsay, N. V., Albores-Saavedra, J., Compton, C., Garrett, E. S., Goodman, S. N., Kern, S. E., Klimstra, D. S., Kloppel, G., Longnecker, D. S., Luttges, J., and Offerhaus, G. J. Pancreatic intraepithelial neoplasia: a new nomenclature and classification system for pancreatic duct lesions. Am. J. Surg. Pathol., 25: 579-586, 2001.
17. Kloppel G., Solcia E., Longnecker D. S., Capella C., and Sobin L. H. WHO: Histological Typing of Tumours of the Exocrine Pancreas, Ed. 2. Berlin: Springer-Verlag, 1996.
18. UICC: TNM Classification of Malignant Tumors. New York: Wiley Press, 1997.
19. Hahn, S. A., Seymour, A. B., Hoque, A. T., Schutte, M., da Costa, L. T., Redston, M. S., Caldas, C., Weinstein, C. L., Fischer, A., Yeo, C. J., and et al. Allelotype of pancreatic adenocarcinoma using xenograft enrichment. Cancer Res., 55: 4670-4675, 1995.
20. Ouyang, H., Mou, L., Luk, C., Liu, N., Karaskova, J., Squire, J., and Tsao, M. S. Immortal human pancreatic duct epithelial cell lines with near normal genotype and phenotype. Am. J. Pathol., 157: 1623-1631, 2000.
21. Jaffee, E. M., Schutte, M., Gossett, J., Morsberger, L. A., Adler, A. J., Thomas, M., Greten, T. F., Hruban, R. H., Yeo, C. J., and Griffin, C. A. Development and characterization of a cytokine-secreting pancreatic adenocarcinoma vaccine from primary tumors for use in clinical trials. Cancer J. Sci. Am., 4: 194-203, 1998.
22. Ueki, T., Toyota, M., Skinner, H., Walter, K. M., Yeo, C. J., Issa, J. P., Hruban, R. H., and Goggins, M. Identification and characterization of differentially methylated CpG islands in pancreatic carcinoma. Cancer Res., 61: 8540-8546, 2001.
23. Herman, J. G., Graff, J. R., Myohanen, S., Nelkin, B. D., and Baylin, S. B. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc. Natl. Acad. Sci. USA, 93: 9821-9826, 1996.
24. Bouchard, J., and Momparler, R. L. Incorporation of 5-aza-2′-deoxycytidine-5′-triphosphate into DNA. Interactions with mammalian DNA polymerase α and DNA methylase. Mol. Pharmacol., 24: 109-114, 1983.
25. Yoshida, M., Horinouchi, S., and Beppu, T. Trichostatin A and trapoxin: novel chemical probes for the role of histone acetylation in chromatin structure and function. Bioessays, 17: 423-430, 1995.
26. Matsubayashi, H., Watanabe, H., Ajioka, Y., Nishikura, K., Yamano, M., Seki, T., and Saito, T. Different amounts of K-ras mutant epithelial cells in pancreatic carcinoma and mass-forming pancreatitis. Pancreas, 21: 77-85, 2000.
27. Hruban, R. H., Wilentz, R. E., and Kern, S. E. Genetic progression in the pancreatic ducts. Am. J. Pathol., 156: 1821-1825, 2000.
28. Somogyi, L., Cintron, M., and Toskes, P. P. Synthetic porcine secretin is highly accurate in pancreatic function testing in individuals with chronic pancreatitis. Pancreas, 21: 262-265, 2000.
29. Issa, J. P. Epigenetic variation and human disease. J. Nutr., 132: 2388S-2392S, 2002.
30. Toyota, M., and Issa, J. P. CpG island methylator phenotypes in aging and cancer. Semin. Cancer Biol., 9: 349-357, 1999.
31. Issa, J. P. Ahuja, N., Toyota, M., Bronner, M. P., and Brentnall, T. A. Accelerated age-related CpG island methylation in ulcerative colitis. Cancer Res., 61: 3573-3577, 2001.
32. Issa, J. P., Ottaviano, Y. L., Celano, P., Hamilton, S. R., Davidson, N. E., and Baylin, S. B. Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon. Nat. Genet., 7: 536-540, 1994.
33. Uehara, Y., Ono, T., Kurishita, A., Kokuryu, H., and Okada, S. Age-dependent and tissue-specific changes of DNA methylation within and around the c-fos gene in mice. Oncogene., 4: 1023-1028, 1989.
34. Ono, T., Yamamoto, S., Kurishita, A., Yamamoto, K., Yamamoto, Y., Ujeno, Y., Sagisaka, K., Fukui, Y., Miyamoto, M., Tawa, R., and et al. Comparison of age-associated changes of c-myc gene methylation in liver between man and mouse. Mutat. Res., 237: 239-246, 1990.
35. Takano, Y., Kato, Y., Masuda, M., Ohshima, Y., and Okayasu, I. Cyclin D2, but not cyclin D1, overexpression closely correlates with gastric cancer progression and prognosis. J. Pathol., 189: 194-200, 1999.
36. Sicinski, P., Donaher, J. L., Geng, Y., Parker, S. B., Gardner, H., Park, M. Y., Robker, R. L., Richards, J. S., McGinnis, L. K., Biggers, J. D., Eppig, J. J., Bronson, R. T., Elledge, S. J., and Weinberg, R. A. Cyclin D2 is an FSH-responsive gene involved in gonadal cell proliferation and oncogenesis. Nature (Lond.), 384: 470-474, 1996.
37. Jena, N., Deng, M., Sicinska, E., Sicinski, P., and Daley, G. Q. Critical role for cyclin D2 in BCR/ABL-induced proliferation of hematopoietic cells. Cancer Res., 62: 535-541, 2002.
38. Buckley, M. F., Sweeney, K. J., Hamilton, J. A., Sini, R. L., Manning, D. L., Nicholson, R. I., deFazio, A., Watts, C. K., Musgrove, E. A., and Sutherland, R. L. Expression and amplification of cyclin genes in human breast cancer. Oncogene, 8: 2127-2133, 1993.
39. Kornmann, M., Ishiwata, T., Itakura, J., Tangvoranuntakul, P., Beger, H. G., and Korc,. M. Increased cyclin D1 in human pancreatic cancer is associated with decreased postoperative survival. Oncology, 55: 363-369, 1998.
40. Ebert, M. P., Hemberg, S., Fei, G., Sokolowski, A., Schulz, H. U., Lippert, H., and Malfertheiner, P. Induction and expression of cyclin D3 in human pancreatic cancer. J Cancer Res. Clin. Oncol., 127: 449-454, 2001.
41. Clark, S. J., and Warnecke, P. M. DNA methylation analysis in mammalian cells. Methods Enzymol., 27: 99-100, 2002.
42. Kawakami, K., Brabender, J., Lord, R. V., Groshen, S., Greenwald, B. D., Krasna, M. J., Yin, J., Fleisher, A. S., Abraham, J. M., Beer, D. G., Sidransky, D., Huss, H. T., Demeester, T. R., Eads, C., Laird, P. W., Ilson, D. H., Kelsen, D. P., Harpole, D., Moore, M. B., Danenberg, K. D., Danenberg, P. V., and Meltzer, S. J. Hypermethylated APC DNA in plasma and prognosis of patients with esophageal adenocarcinoma. J. Natl. Cancer Inst., 92: 1805-1811, 2000.